Nature Communications (Feb 2024)

Structure of the p53 degradation complex from HPV16

  • John C. K. Wang,
  • Hannah T. Baddock,
  • Amirhossein Mafi,
  • Ian T. Foe,
  • Matthew Bratkowski,
  • Ting-Yu Lin,
  • Zena D. Jensvold,
  • Magdalena Preciado López,
  • David Stokoe,
  • Dan Eaton,
  • Qi Hao,
  • Aaron H. Nile

DOI
https://doi.org/10.1038/s41467-024-45920-w
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Human papillomavirus (HPV) is a significant contributor to the global cancer burden, and its carcinogenic activity is facilitated in part by the HPV early protein 6 (E6), which interacts with the E3-ligase E6AP, also known as UBE3A, to promote degradation of the tumor suppressor, p53. In this study, we present a single-particle cryoEM structure of the full-length E6AP protein in complex with HPV16 E6 (16E6) and p53, determined at a resolution of ~3.3 Å. Our structure reveals extensive protein-protein interactions between 16E6 and E6AP, explaining their picomolar binding affinity. These findings shed light on the molecular basis of the ternary complex, which has been pursued as a potential therapeutic target for HPV-driven cervical, anal, and oropharyngeal cancers over the last two decades. Understanding the structural and mechanistic underpinnings of this complex is crucial for developing effective therapies to combat HPV-induced cancers. Our findings may help to explain why previous attempts to disrupt this complex have failed to generate therapeutic modalities and suggest that current strategies should be reevaluated.